Medindia

X

Cyberkinetics Requests FDA to Sell Nerve Growth Stimulation System

by Medindia Content Team on  February 24, 2007 at 2:53 PM Research News   - G J E 4
Cyberkinetics Requests FDA to Sell Nerve Growth Stimulation System
Cyberkinetics, Inc, winner of the Medgadget "Most Sci-Fi Sounding Company Name" Award, has asked the FDA for permission to market their Andara OFS nerve growth stimulation system.
Advertisement

According to Cyberkinetics, "Cyberkinetics' Andara™ OFS™ System consists of a battery-powered device about the size of a cardiac pacemaker with six electrical leads. Three of the leads are attached to the vertebrae at a distance of two disk-segments above the area of injury, and three are attached to the vertebrae at a distance of two disk-segments below the injury. By applying an oscillating, low-voltage, direct current of electricity to the areas above and below a spinal cord injury, the Andara™ OFS™ System creates an electrical field that surrounds the injury and stimulates the nerves surrounding the spinal cord to grow and form new connections that can restore sensory and motor function. The Andara™ OFS™ System is an investigational device. It is not currently approved for sale and is available only through participation in a clinical study.

Advertisement
Cyberkinetics has filed an application for Humanitarian Use Device status from the FDA. If the application is successful, Cyberkinetics could market the device commercially in late 2007.

Basically, the new humanitarian exemption would mean that they could actually sell the device, rather than only use it through clinical trials.

Source: Bio-Bio Technology
SRM
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: